*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Advisor: Gilda Barabino, Ph.D. (Georgia Institute of Technology)
Committee:
Robert Guldberg, Ph.D. (Georgia Institute of Technology)
Todd McDevitt, Ph.D. (Georgia Institute of Technology)
Raymond Vito, Ph.D. (Georgia Institute of Technology)
Jaroslava Halper, M.D., Ph.D. (University of Georgia)
Tissue engineering holds promise to produce functional tissue replacements suitable for implantation and thereby represents a potential long-term strategy for cartilage repair. The interplay between environmental factors, however, gives rise to complex culture conditions that influence the development of tissue-engineered constructs. A fibrous capsule that is composed of abundant type I collagen molecules and resembles fibrocartilage usually forms at the outer edge of tissue-engineered cartilage, yet the understanding of its modulation by environmental cues is still limited. Therefore, this dissertation was aimed to characterize the capsule formation, development and function through manipulation of biochemical parameters present in a hydrodynamic environment while a chemically reliable media preparation protocol for hydrodynamic cultivation of neocartilage was established. To this end, a novel wavy-wall bioreactor that imparts turbulent flow-induced shear stress was employed as the model system and chondrocyte-seed constructs were cultivated under varied biochemical conditions.
Our results demonstrated that tissue morphology, biochemical composition and mechanical strength of hydrodynamically engineered cartilage were maintained as the serum content decreased by 80% (from 10% to 2%). Transient exposure of the low-serum constructs to exogenous insulin-like growth factor-1 (IGF-1) or transforming growth factor-β1 (TGF-β1) further accelerated their development in comparison with continuous treatment with the same bioactive molecules. The process of the capsule formation was found to be activated and modulated by the concentration of serum which contains soluble factors that are able to induce fibrotic processes and the capsule development was further promoted by fluid shear stress. Moreover, the capsule formation in hydrodynamic cultures was identified as a potential biphasic process in response to concentrations of fibrosis-promoting molecules such as TGF-β. Finally, the presence of the fibrous capsule at the construct periphery was shown to effectively improve the ability of engineered cartilage to integrate with native cartilage tissues, but evidently compromise its tissue homogeneity.
Characterization of the fibrous capsule and elucidation of the conditions under which it is formed provide important insights for the development of tissue engineering strategies to fabricate clinically relevant cartilage tissue replacements that possess optimized tissue homogeneity and properties while retaining a minimal capsule thickness required to enhance tissue integration.
